Dr. Chong Yin | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Chong Yin | Medicine | Best Researcher Award

Dr. Chong Yin | Associate Researcher | Affiliated Hospital of North Sichuan Medical College | China

Academic Background

Chong Yin holds a comprehensive academic background in biotechnology, animal genetics, and biomedical engineering, progressing from a Bachelor of Science degree in Biotechnology to a Ph.D. in Biomedical Engineering. His educational foundation has equipped him with a strong interdisciplinary understanding of molecular biology, genetic research, and biomedical applications. His work has been widely recognized and cited across multiple scientific platforms, with over fifteen hundred citations by more than thirteen hundred documents. His research output spans over fifty documents, reflecting a significant and sustained contribution to the field. With an h-index of twenty-two, as recorded on Scopus and Google Scholar, his influence in osteogenic and molecular biology research continues to grow.

Research Focus

Chong Yin’s research focuses on the molecular mechanisms governing bone biology, particularly osteoporosis, and the development of nucleic acid-based therapeutics. His work integrates phase separation, gene editing, and hydrogel technologies to explore novel strategies for enhancing bone regeneration and repair. He aims to bridge fundamental cellular biology with translational therapies for skeletal diseases, focusing on innovative approaches for osteogenic differentiation and bone metabolism.

Work Experience

Chong Yin began his professional career as a graduate assistant at the University of Mississippi Medical Center, where he contributed to foundational biomedical research. He then undertook postdoctoral research at Northwestern Polytechnical University, further refining his expertise in cellular and molecular biology. He currently serves as an Associate Researcher and Associate Professor at the Affiliated Hospital of North Sichuan Medical College, where he leads multiple research initiatives in bone biology and regenerative medicine.

Key Contributions

Chong Yin has made substantial contributions to understanding osteoblast differentiation, bone formation, and mechanotransduction in skeletal tissues. He has pioneered studies on long noncoding RNAs and microRNAs that regulate bone metabolism and developed biomimetic hydrogels with applications in osteomyelitis treatment. His work has provided valuable insights into the biomechanical mechanisms underlying bone remodeling and the therapeutic potential of RNA-based and hydrogel-mediated interventions.

Awards & Recognition

Chong Yin’s contributions have been recognized with prestigious national and international awards, including grants for young investigators and accolades for innovative research in skeletal disease treatment. His work has garnered recognition for advancing translational approaches in bone biology and regenerative medicine.

Professional Roles & Memberships

He is an active member of multiple scientific societies, including the International Chinese Musculoskeletal Research Society, the Chinese Society of Cell Biology, and the Chinese Anti-cancer Association. He serves as a young editorial member for journals such as iMeta and Burns & Trauma, reflecting his growing influence in scientific publishing and peer review.

Profile

Scopus

Featured Publications

Yin, C., Tian, Y., Yu, Y., et al. Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p. Pharmacol Res.

Yin, C., Tian, Y., Li, D., et al. Long non-coding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p. Iscience.

Hu, L., Yin, C., Chen, D., et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ.

Tian, Y., Zhao, Y., Yin, C., et al. Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery. J Control Release.

Yin, C., Zhang, Y., Hu, L., et al. Mechanical unloading reduces microtubule actin crosslinking factor 1 expression to inhibit β-catenin signaling and osteoblast proliferation. J Cell Physiol.

Impact Statement / Vision

Chong Yin envisions advancing the field of bone biology by translating molecular insights into practical therapies that improve patient outcomes. His research aims to integrate genetic, biochemical, and biomaterial strategies to address skeletal disorders and enhance regenerative medicine approaches, establishing a framework for innovative and clinically relevant treatments.

Konstantinos Fousekis | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Prof. Konstantinos Fousekis | Medicine | Best Researcher Award

Professor | University of Patras | Greece

Prof. Konstantinos Fousekis is a distinguished academic and researcher in the field of physiotherapy, currently serving as Professor in the Department of Physiotherapy at the University of Patras. He is recognized for his expertise in the physiotherapeutic assessment of sports injuries and for directing the Laboratory of Therapeutic Exercise and Sports Rehabilitation. His academic journey is marked by contributions to teaching, research, and professional practice, with a strong focus on sports rehabilitation and innovative therapeutic methods. He has made substantial scholarly contributions with more than a hundred publications in international outlets.

Publication Profile

Scopus

Google Scholar

Education Background

Prof. Konstantinos Fousekis pursued his higher education in physiotherapy and related sciences, equipping himself with advanced expertise in sports injury rehabilitation, therapeutic techniques, and applied exercise science. His academic training laid the foundation for a career dedicated to bridging clinical application with academic excellence. Through continuous professional development and participation in national and international projects, he strengthened his knowledge base and expanded his specialization in therapeutic exercise and sports physiotherapy. His educational path has enabled him to shape both undergraduate and postgraduate teaching with evidence-based approaches.

Professional Experience

Prof. Konstantinos Fousekis has extensive professional and academic experience, having served in various administrative and teaching capacities at the University of Patras. He has been Chair of the Department of Physiotherapy, a member of the Dean’s Office of the School of Rehabilitation Sciences, and a member of the University Senate. His teaching portfolio includes core subjects in soft tissue techniques, kinesiotherapy, therapeutic exercise, and sports physiotherapy, alongside advanced postgraduate courses. Professionally, he has applied his expertise in the rehabilitation of musculoskeletal and sports-related disorders, combining research with clinical practice to benefit patients and athletes.

Awards and Honors

Prof. Konstantinos Fousekis has been honored with leadership roles that highlight his professional stature, including his appointment as President of the Scientific Committee of the Panhellenic Association of Physiotherapists. In this capacity, he contributes to advancing certification standards for sports physiotherapists in Greece. He also serves as Scientific Director of lifelong learning programs at the University of Patras, reflecting recognition of his commitment to advancing physiotherapy education. His contributions to textbooks, particularly a Greek manual on applied sports physiotherapy, and his involvement in national and international projects, further underline his professional recognition.

Research Focus

His primary research interests are centered on the rehabilitation of sports injuries, the development of innovative soft tissue techniques, and therapeutic interventions that optimize athletic performance. Prof. Fousekis has contributed to advancing knowledge on the effectiveness of physiotherapy methods in clinical and sports contexts. His work includes systematic reviews, applied sports physiotherapy studies, and explorations of novel interventions like motor imagery in rehabilitation. His ongoing research continues to support evidence-based practice, while his role as a reviewer for international journals ensures active engagement with the latest scientific developments in his field.

Publications Notes

Title: The effectiveness of the Cyriax Method in the treatment of lateral elbow tendinopathy: A systematic review
Published Year: 2025
Citation: 1

Title: Assessment of Injury Risk in Professional Soccer Players: A Long-Term Study
Published Year: 2025
Citation: 1

Title: The Complementary Role of Motor Imagery on VO2max and Lactate in Professional Football Players with Grade II Ankle Sprains During the Return-to-Play Period
Published Year: 2025
Citation: 1

Conclusion

Prof. Konstantinos Fousekis stands out as an accomplished academic and practitioner who integrates teaching, research, and clinical expertise in physiotherapy. His contributions to sports rehabilitation, professional leadership, and commitment to innovation mark him as a leading figure in the physiotherapy discipline. Through his publications, teaching, and professional engagement, he has influenced both national and international physiotherapy practices. His role as a mentor, researcher, and professional leader reflects his enduring impact on the advancement of physiotherapy science and education.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Dr. Jayalakshmi Mariakuttikan , Associate Professor , Madurai Kamaraj University , India.

Dr. M. Jayalakshmi, Ph.D., is a distinguished Associate Professor and Head of the Department of Immunology at the School of Biological Sciences, Madurai Kamaraj University, Tamil Nadu. Since 2005, she has dedicated her research to immunogenetics, focusing on disease susceptibility in South Indian populations. With postdoctoral training from UCSF, USA, and a prolific academic journey, she has mentored numerous scholars and spearheaded advanced research projects. She has delivered over 110 invited talks, published 40+ international papers, and contributed to impactful policy research. Her commitment to immunology and education underscores her stature as a respected academician and researcher in biomedical science.

Publication Profile

Scopus

Google Scholar

🎓 Education Background

Dr. Jayalakshmi earned her Ph.D. in Immunogenetics from Manonmaniam Sundaranar University, conducting her doctoral research at Holy Cross College, Nagercoil. She ranked first in her B.Sc. and M.Sc. (Zoology) programs from the same university, showcasing academic excellence early on. Her M.Phil. at St. Xavier’s College, Palayamkottai, also saw her secure the top rank. She further enhanced her expertise through a prestigious Raman Postdoctoral Fellowship at the University of California, San Francisco (UCSF), focusing on transplantation immunogenetics. Her strong academic foundation and exposure to global research platforms empower her ongoing scientific contributions in immunogenetics and molecular diagnostics.

🧪 Professional Experience

Dr. M. Jayalakshmi began her career as an Assistant Professor in 2005 at Madurai Kamaraj University and has served as Associate Professor and Head since 2017. Her academic leadership includes coordinating molecular diagnostic training, spearheading RUSA-funded research facilities, and serving as a syndicate member at MKU. She has also mentored numerous M.Sc. and Ph.D. students. With experience spanning teaching, research, and administration, she has organized skill development programs benefiting over 1,100 students. Additionally, she plays key roles in academic boards, ethics committees, and national curriculum development, consistently contributing to life science education and translational biomedical research.

🏅 Awards and Honors

Dr. Jayalakshmi’s academic brilliance has earned her multiple prestigious awards. She was a gold medalist and university topper in both B.Sc. and M.Sc. Zoology programs. She received the National Merit Scholarship and CSIR Fellowships during her Ph.D. journey. Her innovative teaching earned her the Gold Medal from Madurai Kamaraj University. She was awarded the UGC-Raman Postdoctoral Fellowship for her research at UCSF, USA, and has served as a DST-INSPIRE Mentor since 2008. Her scholarly contributions include 16 best paper awards at international conferences, reflecting her impactful presence in global immunogenetics research and scientific communication.

🔬 Research Focus

Dr. Jayalakshmi’s research centers on the immunogenetics of breast cancer, autoimmune disorders (Type 1 Diabetes, RHD), infectious diseases (HIV, HBV), and chronic kidney disease. Since 2005, she has analyzed the South Indian population’s genetic profiles using advanced tools like PCR and Next-Generation Sequencing. Her studies aim to identify genetic susceptibility markers and early diagnostic tools, contributing significantly to personalized medicine. Her lab has also explored microbiomes and HLA allele associations through funded research projects. With over 120 gene sequences and 14 whole-genome submissions to NCBI, her team’s research outcomes have international implications in immunogenomics and translational diagnostics.

🧭 Conclusion

Dr. M. Jayalakshmi exemplifies excellence in education, research, and scientific leadership in immunogenetics. Her pioneering work across cancer, infectious diseases, and autoimmune disorders in South India has advanced diagnostic research and molecular epidemiology. With a global research footprint, numerous scholarly contributions, and unwavering dedication to mentorship and innovation, she continues to inspire students and scientists alike. Through her active role in academic councils and ethical boards, she advocates for responsible science and societal health impact. Her career is a testament to the transformative power of science driven by curiosity, precision, and community engagement.

📚 Top Publication Notes

  1. Impact of unique host genetic variants in the HIV life cycle
    Human Gene (2025) — Differentiates HIV progression among South Indian females.
    Cited by: 5 articles

  2. Genomic Diversity and Antimicrobial Resistance of Acinetobacter sp.
    Indian Journal of Microbiology (2024) — Explores pan-genome and resistance markers.
    Cited by: 2 articles

  3. Association of Vitamin D receptor polymorphisms with Type 1 diabetes
    Journal of Clinical Research in Pediatric Endocrinology (2024) — Highlights VDR polymorphism link to T1D.
    Cited by: 3 articles

  4. The microbiome and rheumatic heart disease
    Acta Cardiologica (2023) — Discusses microbial links to RHD pathogenesis.
    Cited by: 1 article

  5. KIR-HLA ligand association with Type 1 Diabetes
    Immunological Investigations (2023) — Investigates KIR gene role in autoimmune risk.
    Cited by: 4 articles

  6. HLA-DRB1 Alleles with Rheumatic Heart Disease
    Immunological Investigations (2022) — Meta-analysis connecting HLA variants and RHD.
    Cited by: 6 articles

  7. HLA-G 3’UTR polymorphism and breast cancer
    Journal of Clinical Pathology (2020) — Links HLA-G variant with breast cancer susceptibility.
    Cited by: 12 articles